In contrast, the trend toward a lower proportion of elevated carbohydrate antigen 19 − 9 (CA19-9) in the validation cohort did not reach statistical significance (6.3% vs. 10.5%, p = 0.077).
← all excerpts
The prognostic role of inflammation-based hematologic markers in stage I-III colorectal cancer: a retrospective analysis.
1
0.0770
0.0770